HCW Biologics Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2022 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
HCW Biologics Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2022 to Q4 2023.
  • HCW Biologics Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2023 was $28.1K, a 85.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $28.1K -$163K -85.3% Dec 31, 2023 10-K/A 2024-05-15
Q3 2023 $69.6K -$160K -69.7% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $111K -$158K -58.8% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $151K -$155K -50.7% Mar 31, 2023 10-Q/A 2023-08-10
Q4 2022 $191K Dec 31, 2022 10-K 2023-03-28
Q3 2022 $230K Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $268K Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $306K Mar 31, 2022 10-Q 2022-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.